New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 14, 2013
08:14 EDTMDASMedAssets valuation is exceptionally attractive, says RW Baird
Baird believes the valuation of MedAssets is exceptionally attractive and raised its price target to $25 from $24. The firm cited recent contract wins, expansions, and believes it will hit its above Street Q4 guidance. Shares are Outperform rated.
News For MDAS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 27, 2016
10:31 EDTMDASPamplona Capital completes acquisition of MedAssets
Pamplona Capital Management has completed the acquisition of MedAssets. As a result of the transaction, MedAssets stock will stop trading at the close of business today. Pamplona purchased MedAssets for $31.35 per share, which represents a total enterprise value of approximately $2.7B. The transaction was overwhelmingly approved by stockholders on January 14, with 99.8% of total votes cast in favor. Separately, Pamplona has entered into an agreement with Vizient to divest MedAssets' Spend and Clinical Resource Management segment to Vizient. That transaction is expected to be completed in mid-February 2016.
January 26, 2016
18:18 EDTMDASS&P announces changes to S&P 500, S&P SmallCap 600 indices
Subscribe for More Information
17:19 EDTMDASZELTIQ to replace MedAssets in S&P 600 as of 1/29 close
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use